Life Sciences Tools and Services
Company Overview of FoldRx Pharmaceuticals, Inc.
FoldRx Pharmaceuticals, Inc. is a drug discovery and clinical development company which develops disease modifying drug therapies for diseases of protein misfolding and amyloidosis. The company’s pipeline includes a program in advanced clinical development to treat genetic neurologic and cardiovascular disorders, transthyretin-associated amyloidoses with polyneuropathy and TTR-associated amyloidoses with cardiomyopathy, and a discovery program in Parkinson's disease and cystic fibrosis. FoldRx Pharmaceuticals, Inc. was founded in 2003 and is based in Cambridge, Massachusetts. As of October 6, 2010, FoldRx Pharmaceuticals, Inc. operates as a subsidiary of Pfizer Inc.
100 Acorn Park Drive
Cambridge, MA 02140
Founded in 2003
Key Executives for FoldRx Pharmaceuticals, Inc.
Similar Private Companies By Industry
|10X Genomics, Inc.||United States|
|4G Clinical, Inc.||United States|
|AAPharmaSyn LLC||United States|
|Abiant, Inc.||United States|
|aBioBot, Inc.||United States|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
Most Searched Private Companies
|Company Name||Geographic Region|
|Lawyers Committee for Civil Rights Under Law||United States|
|Bloomberg L.P.||United States|
|NYC2012, Inc.||United States|
|The Advertising Council, Inc.||United States|
Sponsored Financial Commentaries
To contact FoldRx Pharmaceuticals, Inc., please visit --. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.